A5100901055- Cancer, Lipids, and Metabolism
- Ferroptosis and cancer prognosis
- Cancer Mechanisms and Therapy
- Circular RNAs in diseases
- Cancer-related Molecular Pathways
- Cholinesterase and Neurodegenerative Diseases
- Advanced Proteomics Techniques and Applications
- Neuroscience and Neuropharmacology Research
- Inflammatory mediators and NSAID effects
- Electronic Packaging and Soldering Technologies
- Estrogen and related hormone effects
- RNA modifications and cancer
- Metallurgical and Alloy Processes
- Pharmacological Receptor Mechanisms and Effects
- 3D IC and TSV technologies
- Cancer, Stress, Anesthesia, and Immune Response
Fudan University
2024-2025
Shenyang Pharmaceutical University
2025
Minhang District Central Hospital
2025
Tianjin Medical University General Hospital
2024
Hebei Medical University
2011
National Cheng Kung University
2004
The proteomic heterogeneity of gastric adenocarcinoma (GC) has been extensively investigated at the bulk tissue level, which can only provide an average molecular state. In this study, we collected in-depth quantitative dataset tissues and interstitial fluids (ISFs) from both poorly non-poorly differentiated GC presented a comprehensive analysis several perspectives. Comparison proteomes between ISFs revealed that ISF exhibited higher abundances proteins associated with blood microparticles,...
The use of celecoxib is associated with a significant decrease in breast cancer risk. However, the long-term high-dose might be limited owing to cardiovascular side effects. In this study, we found that acetylbritannilactone (ABL), extract from Chinese medicinal herb, could reduce dose and potentiate growth-inhibitory effect cells. ABL enhanced apoptotic COX-2-expressing cells, but had little COX-2-negative apoptosis induced by combination treatment disappeared when COX-2 was knocked down,...
To investigate the effect of serine/arginine-rich splicing factor 2 (SRSF2) on ferroptosis and its possible mechanism in glioblastoma cells.
Abstract. Dihydroartemisinin (DHA), a derivative of artemisinin, has been shown to act as chemosensitizer various cancer chemotherapeutic agents both in vitro and vivo. However, colorectal (CRC), no study fo-cused on the effect DHA oxaliplatin (L -OHP) resistance. Our aimed examine effectiveness reversing resistance human CRC cells L -OHP, well its underlying molecular mechanisms. LoVo were purchased from ATCC, while LoVo/L -OHP obtained by exposing progressively increasing concentrations...